BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/25/2025 3:52:08 AM | Browse: 1 | Download: 0
 |
Received |
|
2025-09-17 06:38 |
|
Peer-Review Started |
|
2025-09-17 06:38 |
|
First Decision by Editorial Office Director |
|
2025-10-11 03:10 |
|
Return for Revision |
|
2025-10-11 03:10 |
|
Revised |
|
2025-10-20 09:18 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-11-20 02:29 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-11-21 10:14 |
|
Articles in Press |
|
2025-11-21 10:14 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-12-18 03:06 |
|
Publish the Manuscript Online |
|
2025-12-25 03:52 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cell & Tissue Engineering |
| Manuscript Type |
Review |
| Article Title |
Hurdles to overcome for mesenchymal stem cell translation from bench to bedside
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Naiyareen Fareeza Mayeen, Umme Salma, Noor Hayaty Abu Kasim, Okba Mahmoud and Nazmul Haque |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Nazmul Haque, Chief, Head, PhD, Department of Regenerative Medicine, Concord Stem Cell Limited, 3, Sima Blossom, Road 16, Dhanmondi, Dhaka 1209, Bangladesh. haquen1983@gmail.com |
| Key Words |
Regenerative medicine; Clinical translation; Stem cell expansion; Scaffolds; Immunomodulation; Good manufacturing practice |
| Core Tip |
Regenerative medicine has been practiced in a variety of settings for decades. It is a multidisciplinary branch of medicine that aims at replacing degenerated cells or regenerating new human cells, tissues, or organs that have been lost or damaged due to the effects of aging, illness, or congenital defects. The main objective of regenerative medicines is to restore normal functions of the cells or tissues in patients affected by degenerative disorders. Mesenchymal stem cells (MSCs) have the potential to cure the most critical regions or take over the function of a wounded organ that is considered beyond repair using conventional therapies. In the last two decades, thousands of in vitro, in vivo, and clinical trials have been conducted using MSCs. Though the regenerative potential of MSCs has been extensively studied, there are still a lot of challenges that need to be addressed for their successful translation from bench to bedside. |
| Publish Date |
2025-12-25 03:52 |
| Citation |
Mayeen NF, Salma U, Abu Kasim NH, Mahmoud O, Haque N. Hurdles to overcome for mesenchymal stem cell translation from bench to bedside. World J Stem Cells 2025; 17(12): 114349 |
| URL |
https://www.wjgnet.com/1948-0210/full/v17/i12/114349.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v17.i12.114349 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
